Patti J. Marks

Recent matters include the representation of:

• Macquarie Infrastructure Holdings (NYSE: MIC), on the sale of the MIC Hawaii businesses, a regulated gas utility and unregulated propane distributor, to an affiliate of Argo Infrastructure Partners, LP., by means of a merger of Macquarie Infrastructure Holdings, LLC with a subsidiary of Argo.
• Macquarie Infrastructure Corporation (NYSE: MIC) and its related entities in the US$4.475 billion sale of its Atlantic Aviation business to KKR (NYSE: KKR).
• Falcon Capital Acquisition Corp. (NASDAQ: FCAC), a SPAC, in its US$3.9 billion business combination with Sharecare, Inc., a digital health company based in Georgia.
• CM Life Sciences II (NASDAQ: CMII), a SPAC sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP, in its US$1.23 billion business combination with SomaLogic, Inc., a protein biomarker discovery and clinical diagnostics company.
• Deerfield Healthcare Technology Acquisitions Corp. (NASDAQ: DFHT), a SPAC, in its US$614 million business combination with CareMax Medical Group, L.L.C. and IMC Medical Group Holdings LLC, creating a technology-enabled care platform providing value-based care and chronic disease management to seniors.
• Lantheus Holdings, Inc. (NASDAQ: LNTH), a leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, in its US$500 million acquisition of Progenics Pharmaceuticals, Inc. (NASDAQ: PGNC), an oncology company developing innovative medicines and artificial intelligence to find, fight and follow cancer.
• Sony Corporation of America, a subsidiary of Sony Corporation, in its investment of approximately US$400 million in Bilibili Inc., a China-based provider of online entertainment services, through subscription of new shares.
• FS Development Corp. II (NASDAQ: FSII), a SPAC, in its US$276.2 million business combination with Pardes Biosciences, Inc., an early stage biopharmaceutical company developing a potential direct-acting, oral antiviral drug to treat and prevent SARS-CoV-2 infections.
• FS Development Corp. (NASDAQ: FSDC), a SPAC, in its US$216 million business combination with Gemini Therapeutics, Inc., a clinical stage precision medicine company developing treatments for genetically defined age-related macular degeneration.
• Avast plc (LSE: AVST), one of the world's largest cybersecurity companies, on the carve-out disposal of its Family Safety Mobile Business to Smith Micro Software, Inc. (NASDAQ: SMSI).
• EchoStar Corporation (NASDAQ: SATS), a premier global provider of satellite and video delivery solutions in the tax-free spin-off and subsequent merger of its broadcast satellite service business, including nine satellites and certain real estate owned by EchoStar, with a subsidiary of DISH Network Corporation (NASDAQ: DISH).
• LifePoint Health, Inc. (NASDAQ: LPNT) in its US$5.6 billion merger with RCCH HealthCare Partners, which is owned by certain funds managed by affiliates of Apollo Global Management, LLC (NYSE: APO).
• ETF Securities Ltd. in the sale of its European commodities exchange traded fund business to Wisdom Tree in a US$611 million cash and stock transaction.
• Summit Partners LP and other shareholders of Advance-Medical Health Care Management in the sale of the entire share capital of Advance-Medical Health Care Management to Teladoc, Inc. for an aggregate purchase price of US$340 million, which was settled largely through cash and additional new shares in Teladoc, Inc.
• The Walt Disney Company in its offering and sale of C$1.25 billion aggregate principal amount of its 2.875% Notes due 2024.
• The Walt Disney Company in its offering and sale of US$500 million 2.125% Notes due 2022 and listed on the Luxembourg Stock Exchange.
• The Walt Disney Company with respect to its medium term note and commercial paper programs.
• Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a world leader in musculoskeletal health solutions, in its US$13.35 billion deal to acquire Biomet, Inc., one of the world's leading medical device manufacturers.
• Macquarie Infrastructure Corporation in its offering and sale of US$350 billion aggregate principal amount of its 2.00% Convertible Senior Notes due 2023 in an underwritten public offering.
• LifePoint Health, Inc. in its offering of US$500 million aggregate principal amount of its 5.375% Senior Notes due 2024 through a private offering.
• The underwriters in a US $1.5 billion aggregate principal amount offering of CVS Caremark Corporation's 2.250% Senior Notes due 2019 and 3.375% Senior Notes due 2024.

Prior to joining White & Case, Ms. Marks represented:

• Omnicare, Inc. in its offering of US$500 million 3.75% Convertible Senior Subordinated Notes due 2025.
• Barclays Capital and Goldman Sachs in connection with Dine Equity, Inc.'s private offering of US$825 million 9.5% Senior Notes due 2018 and in related tender offers and consent solicitations, in connection with a US$1.6 billion refinancing by Dine Equity.
• LifePoint Hospitals, Inc. in its offering of US$400 million 6.625% Senior Notes due 2020, the company's inaugural high-yield notes offering.
• Johnson & Johnson in its US$1.1 billion dual-tranche senior notes offering, comprising US$550 million 2.95% notes due 2020 and US$550 million 4.50% notes due 2040.
• Central European Distribution Corporation in concurrent equity and senior secured high-yield notes offerings, aggregating US$1.2 billion in proceeds, comprising 10.25 million shares of common stock, $380 million 9.125% senior secured notes due 2016 and €380 million 8.875% senior secured notes due 2016, to finance, among other things, the acquisition of the Russian Alcohol Group.
• Omnicare, Inc. in a US$2.3 billion financing to fund its acquisition of Neighborcare, Inc., consisting of 30-year contingent convertible bonds, high-yield bonds and common stock.
• The underwriters for offerings aggregating US$2 billion in principal amount of senior notes issued by Staples, Inc., which refinanced short-term indebtedness incurred to finance its acquisition of Corporate Express N.V.
• Triad Hospitals in its acquisition by Community Health Systems.
• The underwriters in various debt offerings for JC Penney Company, Inc.
• Lottomatica S.p.A. in its €1.4 billion equity rights offering and its issuance of €750 million Interest Deferrable Step-up Capital Securities, which constituted part of the financing for Lottomatica's acquisition of GTECH Holdings Corporation, the largest-ever Italian acquisition in the United States.